Silva Pharmaceuticals Limited (DSE:SILVAPHL)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
9.90
+0.20 (2.06%)
At close: Feb 10, 2026
Market Cap1.35B +2.1%
Revenue (ttm)356.99M -28.4%
Net Income-145.41M
EPS-1.07
Shares Out136.50M
PE Ration/a
Forward PEn/a
Dividend0.10 (1.01%)
Ex-Dividend DateDec 2, 2024
Volume160,178
Average Volume264,223
Open9.90
Previous Close9.70
Day's Range9.70 - 10.00
52-Week Range7.60 - 14.40
Beta-0.04
RSI55.60
Earnings DateJan 29, 2026

About Silva Pharmaceuticals

Silva Pharmaceuticals Limited engages in manufacturing and marketing of pharmaceuticals finished products in Bangladesh and internationally. The company offers drugs for various categories, including antibiotics, analgesics, anti-diabetics, narcotics, anti-pyretics, anti-inflammatory, anti ulcerants, antiemetic, gastroprokinetic, antihistamine, anti-spasmodic expectorants, and vitamins and mineral. It also provides pharmaceutical products in therapeutic areas, such as anemias and other blood disorders, central nervous system, gastro- intestinal... [Read more]

Industry Pharmaceutical Preparations
Founded 2001
Employees 624
Stock Exchange Dhaka Stock Exchange
Ticker Symbol SILVAPHL
Full Company Profile

Financial Performance

In fiscal year 2025, Silva Pharmaceuticals's revenue was 383.65 million, a decrease of -36.02% compared to the previous year's 599.66 million. Losses were -132.95 million, 106.2% more than in 2024.

Financial Statements